BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Ark Therapeutics Ltd. 

6 Warren Mews

London    W1T 6AR  United Kingdom
Phone: 44-20-7388-7722 Fax: +44-20-7388-7805


SEARCH JOBS


Industry
Biotechnology






 Company News
Laurantis Pharma Oy and Ark Therapeutics Sign Manufacturing Agreement for Production of Lymfactin™ Investigational Treatment for Breast Cancer-Associated Lymphedema 10/15/2012 9:07:15 AM    More...
Ark Therapeutics Led Consortium Wins €5.3 Million EU Framework Program 7 Grant 7/14/2011 9:22:41 AM    More...
Ark Therapeutics Receives €0.6 Million Finnish Grants for Development of Lentiviral Production Platform 7/6/2011 1:26:15 PM    More...
Ark Therapeutics Interim Management Statement 5/17/2011 10:50:40 AM    More...
Ark Therapeutics Preliminary Results for the Year Ended 31 December 2010 3/9/2011 9:30:05 AM    More...
Ark Therapeutics Release: Appointment of CFO, Russell Banks 3/3/2011 11:22:38 AM    More...
Ark Therapeutics Board Changes, Dr David Bloxham Appointed Non-executive Director 2/22/2011 10:50:15 AM    More...
Ark Therapeutics Release: Disposal of the Majority of the Group's Woundcare Business for up to £2.7 Million 2/8/2011 9:11:02 AM    More...
Positive Results Gor Ark Therapeutics Pre-Clinical Product Candidate EG013 in the Treatment of Foetal Growth Restriction 11/29/2010 11:45:50 AM    More...
Ark Therapeutics Restructures, Cuts Headcount and Looks for Partners 9/9/2010 8:15:56 AM    More...
12345678910

//-->